Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLXPF | ARCT | AURA | ||
Company | Cybin Inc | Arcturus Therapeutics Ltd | Aura Biosciences Inc | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 3.0500 | 17.01 | 9.06 | ||
High | 3.2000 | 17.50 | 9.17 | ||
Low | 2.8736 | 16.20 | 8.92 | ||
Last | 3.0200 | 16.91 | 8.95 | ||
Change | -0.0400 | -0.16 | -0.08 | ||
% Change | -1.31% | -0.94% | -0.89% | ||
Volume | 864,300 | 523,200 | 285,800 | ||
20-Day Average Volume | 1,094,590 | 478,895 | 215,650 | ||
Previous Close | 3.0600 | 17.07 | 9.03 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.8482 | 18.18 | 10.11 | ||
20-Day Raw Stochastic | 71.64% | 29.64% | 9.16% | ||
20-Day Relative Strength | 62.45% | 41.92% | 41.53% | ||
Weighted Alpha | +130.72 | -46.05 | -10.41 | ||
Today's Opinion | N/A | 100% Sell | 40% Buy | ||
Previous Opinion | N/A | 100% Sell | 40% Buy | ||
Last Month's Opinion | N/A | 88% Sell | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +11.46% since 07/28/21 | +5.56% since 11/15/24 | -5.49% since 11/15/24 | ||
Low | 2.7300 on 07/29/21 | 15.50 on 11/21/24 | 8.71 on 11/21/24 | ||
High | 3.3800 on 08/02/21 | 18.09 on 11/19/24 | 9.78 on 11/18/24 | ||
1-Month | |||||
%Chg | +42.45% since 07/02/21 | -14.55% since 10/22/24 | -21.42% since 10/22/24 | ||
Low | 2.1105 on 07/08/21 | 14.93 on 11/15/24 | 8.71 on 11/21/24 | ||
High | 3.3800 on 08/02/21 | 21.61 on 11/11/24 | 11.57 on 10/23/24 | ||
3-Month | |||||
%Chg | +79.76% since 05/04/21 | -21.24% since 08/22/24 | +21.11% since 08/22/24 | ||
Low | 1.3429 on 06/01/21 | 14.93 on 11/15/24 | 7.26 on 09/03/24 | ||
High | 3.3800 on 08/02/21 | 25.88 on 10/02/24 | 12.38 on 10/18/24 | ||
6-Month | |||||
%Chg | +76.61% since 02/04/21 | -47.78% since 05/22/24 | +25.00% since 05/22/24 | ||
Low | 0.9500 on 03/30/21 | 14.93 on 11/15/24 | 6.63 on 06/26/24 | ||
High | 3.3800 on 08/02/21 | 45.00 on 06/05/24 | 12.38 on 10/18/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 453,224 | 458,041 | 447,061 | ||
Shares Outstanding, K | 148,598 | 27,087 | 49,951 | ||
Annual Sales | 650,000 | 166,800,000 | 0 | ||
Annual Net Income | -24,420,000 | -29,730,000 | -76,410,000 | ||
Last Quarter Sales | N/A | 41,670,000 | 0 | ||
Last Quarter Net Income | N/A | -6,900,000 | -21,040,000 | ||
60-Month Beta | N/A | 2.64 | 0.33 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.26 on 11/07/24 | -0.42 on 11/12/24 | ||
Latest Earnings Date | N/A | 11/07/24 | 11/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | 01/04/13 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |